MedTrace Logo

Staging Procedures to Diagnose Malignant Pleural Mesothelioma

NCT02648763 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2025-01-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound and laparoscopy) as part of their standard of care.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dennis Wigle, MD, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-15
Primary Completion
2023-04-22
Completion
2023-04-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02648763 on ClinicalTrials.gov